These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 29438429)

  • 21. Core outcome set in paediatric sepsis in low- and middle-income countries: a study protocol.
    Wooldridge G; Murthy S; Kissoon N
    BMJ Open; 2020 Apr; 10(4):e034960. PubMed ID: 32265242
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protocol for the development of core set of domains of the core outcome set for patients with congenital melanocytic naevi (OCOMEN project).
    Oei W; Fledderus AC; Korfage I; Eggen CAM; van der Horst CMAM; Spuls PI; Brinkmann SJH; Wolkerstorfer A; van Kessel M; Pasmans S
    J Eur Acad Dermatol Venereol; 2020 Feb; 34(2):267-273. PubMed ID: 31419337
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Core outcome sets through the healthcare ecosystem: the case of type 2 diabetes mellitus.
    Dodd S; Harman N; Taske N; Minchin M; Tan T; Williamson PR
    Trials; 2020 Jun; 21(1):570. PubMed ID: 32586349
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcomes for Pressure Ulcer Trials (OUTPUTs): protocol for the development of a core domain set for trials evaluating the clinical efficacy or effectiveness of pressure ulcer prevention interventions.
    Lechner A; Kottner J; Coleman S; Muir D; Bagley H; Beeckman D; Chaboyer W; Cuddigan J; Moore Z; Rutherford C; Schmitt J; Nixon J; Balzer K
    Trials; 2019 Jul; 20(1):449. PubMed ID: 31331366
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Survey indicated that core outcome set development is increasingly including patients, being conducted internationally and using Delphi surveys.
    Biggane AM; Brading L; Ravaud P; Young B; Williamson PR
    Trials; 2018 Feb; 19(1):113. PubMed ID: 29454368
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methods used in the selection of instruments for outcomes included in core outcome sets have improved since the publication of the COSMIN/COMET guideline.
    Gorst SL; Prinsen CAC; Salcher-Konrad M; Matvienko-Sikar K; Williamson PR; Terwee CB
    J Clin Epidemiol; 2020 Sep; 125():64-75. PubMed ID: 32470621
    [TBL] [Abstract][Full Text] [Related]  

  • 27. How to evaluate the clinical outcome of joint-preserving treatment for osteonecrosis of the femoral head: development of a core outcome set.
    Xue Z; Sun J; Li T; Huang Z; Chen W
    J Orthop Surg Res; 2019 Oct; 14(1):317. PubMed ID: 31597557
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of a core outcome set for clinical trials in basal cell carcinoma: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey.
    Schlessinger DI; Iyengar S; Yanes AF; Lazaroff JM; Godinez-Puig V; Chen BR; Kurta AO; Henley JK; Chiren SG; Furlan KC; Schmitt J; Deckert S; Poon E; Sobanko JF; Cartee TV; Alam M; Maher IA
    Trials; 2017 Oct; 18(1):490. PubMed ID: 29061190
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessing the impact of a research funder's recommendation to consider core outcome sets.
    Hughes KL; Kirkham JJ; Clarke M; Williamson PR
    PLoS One; 2019; 14(9):e0222418. PubMed ID: 31518375
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The use of qualitative methods to inform Delphi surveys in core outcome set development.
    Keeley T; Williamson P; Callery P; Jones LL; Mathers J; Jones J; Young B; Calvert M
    Trials; 2016 May; 17(1):230. PubMed ID: 27142835
    [TBL] [Abstract][Full Text] [Related]  

  • 31. COSUTI: a protocol for the development of a core outcome set (COS) for interventions for the treatment of uncomplicated urinary tract infection (UTI) in adults.
    Duane S; Vellinga A; Murphy AW; Cormican M; Smyth A; Healy P; Moore M; Little P; Devane D
    Trials; 2019 Feb; 20(1):106. PubMed ID: 30732617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improving the relevance and consistency of outcomes in comparative effectiveness research.
    Tunis SR; Clarke M; Gorst SL; Gargon E; Blazeby JM; Altman DG; Williamson PR
    J Comp Eff Res; 2016 Mar; 5(2):193-205. PubMed ID: 26930385
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Core outcome domains for clinical trials in non-specific low back pain.
    Chiarotto A; Deyo RA; Terwee CB; Boers M; Buchbinder R; Corbin TP; Costa LO; Foster NE; Grotle M; Koes BW; Kovacs FM; Lin CW; Maher CG; Pearson AM; Peul WC; Schoene ML; Turk DC; van Tulder MW; Ostelo RW
    Eur Spine J; 2015 Jun; 24(6):1127-42. PubMed ID: 25841358
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Core Outcome Set-STAndards for Reporting: The COS-STAR Statement.
    Kirkham JJ; Gorst S; Altman DG; Blazeby JM; Clarke M; Devane D; Gargon E; Moher D; Schmitt J; Tugwell P; Tunis S; Williamson PR
    PLoS Med; 2016 Oct; 13(10):e1002148. PubMed ID: 27755541
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of a core outcome set for clinical trials in inflammatory bowel disease: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey.
    Ma C; Panaccione R; Fedorak RN; Parker CE; Khanna R; Levesque BG; Sandborn WJ; Feagan BG; Jairath V
    BMJ Open; 2017 Jun; 7(6):e016146. PubMed ID: 28601837
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of a core outcome set for clinical trials in facial aging: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey.
    Schlessinger DI; Iyengar S; Yanes AF; Henley JK; Ashchyan HJ; Kurta AO; Patel PM; Sheikh UA; Franklin MJ; Hanna CC; Chen BR; Chiren SG; Schmitt J; Deckert S; Furlan KC; Poon E; Maher IA; Cartee TV; Sobanko JF; Alam M
    Trials; 2017 Aug; 18(1):359. PubMed ID: 28764734
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of a Core Outcome Set and Minimum Reporting Set for intervention studies in growth restriction in the NEwbOrN (COSNEON): study protocol for a Delphi study.
    Knol M; Wang H; Bloomfield F; Piet T; Damhuis S; Khalil A; Ganzevoort W; Gordijn S
    Trials; 2019 Aug; 20(1):511. PubMed ID: 31420053
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A core outcome set for clinical trials on non-specific low back pain: study protocol for the development of a core domain set.
    Chiarotto A; Terwee CB; Deyo RA; Boers M; Lin CW; Buchbinder R; Corbin TP; Costa LO; Foster NE; Grotle M; Koes BW; Kovacs FM; Maher CG; Pearson AM; Peul WC; Schoene ML; Turk DC; van Tulder MW; Ostelo RW
    Trials; 2014 Dec; 15():511. PubMed ID: 25540987
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Core outcomes in periodontal trials: study protocol for core outcome set development.
    Lamont TJ; Clarkson JE; Ricketts DNJ; Heasman PA; Ramsay CR
    Trials; 2017 Sep; 18(1):436. PubMed ID: 28931440
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Toward Developing a Standardized Core Set of Outcome Measures in Mobile Health Interventions for Tuberculosis Management: Systematic Review.
    Lee S; Lee Y; Lee S; Islam SMS; Kim SY
    JMIR Mhealth Uhealth; 2019 Feb; 7(2):e12385. PubMed ID: 30777847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.